Diagnos Inc.
ADK.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -21.43% | 9.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -21.43% | 9.38% | |||
| Cost of Revenue | -3.71% | 31.66% | |||
| Gross Profit | 2.79% | -33.07% | |||
| SG&A Expenses | -1.19% | -31.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.12% | -16.76% | |||
| Operating Income | 1.76% | 17.13% | |||
| Income Before Tax | 1.07% | 13.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.07% | 13.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.07% | 13.65% | |||
| EBIT | 1.76% | 17.13% | |||
| EBITDA | 1.88% | 19.54% | |||
| EPS Basic | 1.27% | 15.96% | |||
| Normalized Basic EPS | 0.00% | 16.95% | |||
| EPS Diluted | 1.27% | 15.96% | |||
| Normalized Diluted EPS | 0.00% | 16.95% | |||
| Average Basic Shares Outstanding | 0.39% | 2.91% | |||
| Average Diluted Shares Outstanding | 0.39% | 2.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||